title: Delineating Alzheimer's disease progression with MGAT3, a biomarker for improved prognosis and personalized therapy.
authors: Milan
authors: M
authors: Fiala
authors: Verna
authors: V
authors: Porter
mesh_terms: D000544:Alzheimer Disease / Q000175:diagnosis* / Q000473:pathology / Q000628:therapy; D016229:Amyloid beta-Peptides / Q000378:metabolism; D015415:Biomarkers / Q000378:metabolism; D002762:Cholecalciferol / Q000627:therapeutic use; D003474:Curcumin / Q000031:analogs & derivatives / Q000627:therapeutic use; D036381:Diarylheptanoids; D018450:Disease Progression; D006801:Humans; D007963:Leukocytes, Mononuclear / Q000378:metabolism; D017351:N-Acetylglucosaminyltransferases / Q000235:genetics / Q000378:metabolism*; D010587:Phagocytosis; D057285:Precision Medicine; D011379:Prognosis
chemical_list: D016229:Amyloid beta-Peptides; D015415:Biomarkers; D036381:Diarylheptanoids; D002762:Cholecalciferol; C034786:bisdemethoxycurcumin; D017351:N-Acetylglucosaminyltransferases; C054599:beta-1,4-mannosyl-glycoprotein beta-1,4-N-acetylglucosaminyltransferase; D003474:Curcumin